HealthEquity's Fiscal Q3 Non-GAAP Earnings, Revenue Rise
HealthEquity (HQY) reported fiscal Q3 non-GAAP diluted earnings Tuesday of $0.60 a share, up from $0.38 a year earlier.
Wells Fargo Maintains Overweight on HealthEquity, Raises Price Target to $93
Wells Fargo analyst Stan Berenshteyn maintains HealthEquity (NASDAQ:HQY) with a Overweight and raises the price target from $89 to $93.
HealthEquity (HQY) Benefitted From Increased Demand
HealthEquity Inc (HQY) Reports Robust Revenue Growth and Profitability in Q3 FY24
HealthEquity: Q3 Earnings Insights
HealthEquity (NASDAQ:HQY) reported its Q3 earnings results on Tuesday, December 5, 2023 at 04:01 PM.Here's what investors need to know about the announcement.EarningsHealthEquity beat estimated earnin
Express News | HealthEquity Sees FY24 Adj. EPS $2.08-$2.16 Vs $2.02 Est., Revenue $985M-$995M Vs $989M Est
Express News | HealthEquity Q3 Adj $0.60 Beats $0.50 Estimate
Earnings Flash (HQY) HEALTHEQUITY Reports Q3 Revenue $249.2M, Vs. Street Est of $243.6M
04:02 PM EST, 12/05/2023 (MT Newswires) -- Earnings Flash (HQY) HEALTHEQUITY Reports Q3 Revenue $249.2M, vs. Street Est of $243.6M
Earnings Flash (HQY) HEALTHEQUITY Reports Q3 EPS $0.60, Vs. Street Est of $0.50
04:02 PM EST, 12/05/2023 (MT Newswires) -- Earnings Flash (HQY) HEALTHEQUITY Reports Q3 EPS $0.60, vs. Street Est of $0.50
Earnings Scheduled For December 5, 2023
Companies Reporting Before The Bell • Core & Main (NYSE:CNM) is expected to report quarterly earnings at $0.69 per share on revenue of $1.83 billion. • AutoZone (NYSE:AZO) is estimated to report quart
Notable Earnings After Tuesday's Close
HealthEquity Q3 2024 Earnings Preview
Barrington Research Reiterates Outperform on HealthEquity, Maintains $85 Price Target
Barrington Research analyst Alexander Paris reiterates HealthEquity with a Outperform and maintains $85 price target.
HealthEquity Poised for Strong Growth and Market Leadership: A Buy Rating With Significant Upside Potential
HealthEquity (HQY) Just Overtook the 20-Day Moving Average
Earnings Outlook For HealthEquity
HealthEquity (NASDAQ:HQY) is set to give its latest quarterly earnings report on Tuesday, 2023-12-05. Here's what investors need to know before the announcement.Analysts estimate that HealthEquity wil
Earnings Week Ahead: DocuSign, NIO, Broadcom, GameStop and More
The first full week of December features several significant companies slated to announce their quarterly results. These earnings releases hold considerable implications for various sectors, including energy, software, retail, autos and semiconductors.
JP Morgan Maintains Overweight on HealthEquity, Lowers Price Target to $73
JP Morgan analyst Anne Samuel maintains HealthEquity (NASDAQ:HQY) with a Overweight and lowers the price target from $81 to $73.
HealthEquity Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 12/01/2023 5.64% JP Morgan $81 → $73 Maintains Overweight 09/21/2023 25.9% Baird $79 → $87 Upgrades Neutra
HealthEquity (NASDAQ:HQY) Has A Pretty Healthy Balance Sheet
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' When we thi